BEXIMCO PHARMA.GDR REGS 1 Financial Flexibility Index
BEXIMCO PHARMA.GDR REGS 1 financial flexibility index. BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Financial Flexibility Index of 0.61x as of June 2024. Free cash flow of €10.60 Billion (operating CF €8.36 Billion minus capex €2.23 Billion) represents 1% of total liabilities (€17.44 Billion). See R2WA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BEXIMCO PHARMA.GDR REGS 1 (2022–2024)
Financial flexibility index of BEXIMCO PHARMA.GDR REGS 1 from 2022 to 2024. Historical Financial Flexibility Index trend for BEXIMCO PHARMA.GDR REGS 1 across 3 annual periods. Check earnings quality score of BEXIMCO PHARMA.GDR REGS 1 to evaluate the quality of earnings relative to operating cash generation.
BEXIMCO PHARMA.GDR REGS 1 Financial Flexibility Index by Year (2022–2024)
BEXIMCO PHARMA.GDR REGS 1 financial flexibility index by year from 2022 to 2024. Year-by-year free cash flow to debt coverage for BEXIMCO PHARMA.GDR REGS 1. For the full cash flow conversion analysis, see BEXIMCO PHARMA.GDR REGS 1 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.61x | €10.60 Billion | €8.36 Billion | €17.44 Billion | ▲ +48.8% |
| 2023 | 0.41x | €8.79 Billion | €6.08 Billion | €21.54 Billion | ▲ +7.7% |
| 2022 | 0.38x | €8.15 Billion | €5.21 Billion | €21.51 Billion | — |